Filed Pursuant to Rule 424(b)(2)
Registration No. 333-232144
 |  | Amendment dated April 28, 2022 to the Pricing Supplements for the Exchange-Traded Notes set forth in Schedule A, to the Prospectus dated August 1, 2019, the Prospectus Supplement dated August 1, 2019 and the Prospectus Supplement Addendum dated February 18, 2021 |
Barclays Bank PLC iPath® Exchange-Traded Notes
This amendment amends and supplements the applicable pricing supplement for each series of exchange-traded notes issued by Barclays Bank PLC set forth in Schedule A below (the “ETNs”). The terms of each series of ETNs are as described in the most recent pricing supplement relating to that series of ETNs (each, a “Pricing Supplement”) and include the specific amendments described below. Terms used but not defined herein have the meanings given to them in the applicable Pricing Supplement.
No Further Sales or Issuances: Effective as of the open of trading on April 28, 2022, we will suspend, until further notice, any further sales from inventory and any further issuances of each series of the ETNs, and neither we nor any of our affiliates will engage in purchase or resale transactions in the ETNs. As a result of this modification, each Pricing Supplement is amended to reflect this suspension.
Risk Factors: As described in each Pricing Supplement, the market value of the ETNs may be influenced by, among other things, the levels of supply and demand for such ETNs. It is possible that this suspension may influence the market value of the ETNs. Barclays Bank PLC believes that the limitations on issuance and sale implemented may cause an imbalance of supply and demand in the secondary market for the ETNs, which may cause the ETNs to trade at a premium or discount in relation to their indicative value. Therefore, any purchase of the ETNs in the secondary market may be at a purchase price significantly different from their indicative value. In particular, paying a premium purchase price over the indicative value of the ETNs could lead to significant losses in the event you sell your ETNs at a time when such premium is no longer present in the marketplace or if we redeem the ETNs at our discretion. Investors should consult their financial advisors before purchasing or selling the ETNs, especially ETNs trading at a premium over their indicative value. Furthermore, if you sell your ETNs at a price which reflects a discount below the intraday indicative value, you may experience a significant loss.
You may lose all or a substantial portion of your investment if you invest in the ETNs. Any payment on the ETNs at or prior to maturity, including any repayment of principal, is not guaranteed by any third party and is subject to the creditworthiness of Barclays Bank PLC. See “Risk Factors” in the Pricing Supplement and “Risk Factors” in the accompanying prospectus supplement for more information.
The ETNs may not be suitable for all investors. Investors should consult with their broker or financial advisor when making an investment decision and to evaluate their investment in the ETNs.
The ETNs are not deposit liabilities of Barclays Bank PLC and are not insured by the United States Federal Deposit Insurance Corporation or any other governmental agency of the United States, the United Kingdom or any other jurisdiction.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these ETNs or determined that this amendment or any Pricing Supplement is truthful or complete. Any representation to the contrary is a criminal offense.

Amendment dated April 28, 2022
to the Pricing Supplements for the Exchange-Traded Notes set forth in Schedule A
You should read this amendment and the applicable Pricing Supplement together with the prospectus dated August 1, 2019, as supplemented by the prospectus supplement dated August 1, 2019 relating to our Global Medium-Term Notes, Series A, of which the ETNs are a part, and the prospectus supplement addendum dated February 18, 2021. You may access these documents on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):
| · | Prospectus dated August 1, 2019: |
http://www.sec.gov/Archives/edgar/data/312070/000119312519210880/d756086d424b3.htm
| · | Prospectus Supplement dated August 1, 2019: |
http://www.sec.gov/Archives/edgar/data/312070/000095010319010190/dp110493_424b2-prosupp.htm
| · | Prospectus Supplement Addendum dated February 18, 2021: |
http://www.sec.gov/Archives/edgar/data/312070/000095010321002483/dp146316_424b3.htm

SCHEDULE A
This Amendment applies to all exchange-traded notes issued by Barclays Bank PLC specified in the table below.
Name of ETN | Ticker | Exchange | CUSIP |
iPath® Bloomberg Commodity Index Total ReturnSM ETN | DJP | NYSE Arca | 06738C778 |
iPath® Shiller CAPE™ Index ETN | CAPD | NYSE Arca | 06742A669 |
iPath® Select MLP ETN | ATMP | CBOE BZX | 06742C723 |
iPath® Series B Bloomberg Copper Subindex Total ReturnSM ETN | JJC | NYSE Arca | 06746P555 |
iPath® Series B Carbon ETN | GRN | NYSE Arca | 06747C322 |
iPath® Series B Bloomberg Coffee Subindex Total ReturnSM ETN | JO | NYSE Arca | 06746P563 |
iPath® Series B Bloomberg Grains Subindex Total ReturnSM ETN | JJG | NYSE Arca | 06746P522 |
iPath® Series B S&P 500® VIX Mid-Term FuturesTM ETNs | VXZ | CBOE BZX | 06746P613 |
iPath® Series B Bloomberg Nickel Subindex Total ReturnSM ETN | JJN | NYSE Arca | 06746P480 |
iPath® Pure Beta Broad Commodity ETN | BCM | NYSE Arca | 06740P114 |
iPath® S&P GSCI® Total Return Index ETN | GSP | NYSE Arca | 06738C794 |
Pacer® iPath® Gold ETN | GBUG | NYSE Arca | 06747D809 |
iPath® Series B Bloomberg Cotton Subindex Total ReturnSM ETN | BAL | NYSE Arca | 06746P548 |
iPath® Series B Bloomberg Tin Subindex Total ReturnSM ETN | JJT | NYSE Arca | 06746P431 |
iPath® Series B Bloomberg Sugar Subindex Total ReturnSM ETN | SGG | NYSE Arca | 06746P449 |
iPath® Series B Bloomberg Agriculture Subindex Total ReturnSM ETN | JJA | NYSE Arca | 06746P589 |
iPath® Series B Bloomberg Industrial Metals Subindex Total ReturnSM ETN | JJM | NYSE Arca | 06746P514 |
iPath® Bloomberg Cocoa Subindex Total ReturnSM ETN | NIB | NYSE Arca | 06739H313 |
iPath® Series B Bloomberg Aluminum Subindex Total ReturnSM ETN | JJU | NYSE Arca | 06746P571 |
Pacer® iPath® Gold Trendpilot ETN | PBUG | NYSE Arca | 06747T382 |
iPath® Series B Bloomberg Livestock Subindex Total ReturnSM ETN | COW | NYSE Arca | 06746P498 |
iPath® Series B Bloomberg Softs Subindex Total ReturnSM ETN | JJS | NYSE Arca | 06746P456 |
iPath® Silver ETN | SBUG | NYSE Arca | 06747D700 |
iPath® S&P MLP ETN | IMLP | CBOE BZX | 06742A750 |
iPath® Series B Bloomberg Energy Subindex Total ReturnSM ETN | JJE | NYSE Arca | 06746P530 |
iPath® Series B Bloomberg Precious Metals Subindex Total ReturnSM ETN | JJP | NYSE Arca | 06746P464 |
iPath® Series B Bloomberg Platinum Subindex Total ReturnSM ETN | PGM | NYSE Arca | 06746P472 |
Barclays Women in Leadership ETN | WIL | CBOE BZX | 06742W430 |
Barclays Return on Disability ETN | RODI | CBOE BZX | 06740D830 |
iPath® Bloomberg Lead Subindex Total ReturnSM ETN | LD | NYSE Arca | 06739H263 |